marketinsider

Is Your Investment in Applied Materials Inc. (AMAT) at Risk? Levi & Korsinsky Investigates Possible Fraud

An Investigation into Applied Materials, Inc. Recently, Levi & Korsinsky announced that they are looking into possible violations of federal securities laws by Applied Materials, Inc. This comes after the investment research firm Hedgeye released a report on October 15, 2024, adding Applied Materials as a new short idea. A Closer Look at the Allegations…

Read More

Bitcoin Billionaire or Bluff? Craig Wright Refutes Contempt Charges in $1.2B Lawsuit Against Bitcoin Core and Square

Australian Computer Scientist Craig Wright Faces Contempt of Court Case Judge Puts Lawsuit Against BTC Core Developers and Square on Hold Australian computer scientist and self-proclaimed Bitcoin inventor Craig Wright is currently facing a contempt of court case over his ongoing lawsuit against BTC Core developers and Jack Dorsey’s Square. The case has caught the…

Read More

Get the Scoop on Clear Channel Outdoor Holdings Inc.’s Q3 2024 Earnings Call: A Play-by-Play Breakdown for Fellow Investors!

Welcome to the Clear Channel Outdoor Holdings, Inc.’s 2024 Third Quarter Earnings Conference Call! October 31, 2024, 8:30 AM ET Company Participants: Eileen McLaughlin – Vice President, Investor Relations Scott Wells – Chief Executive Officer David Sailer – Executive Vice President and Chief Financial Officer Justin Cochrane – Chief Executive Officer, UK and Europe Good…

Read More

Unlocking the Potential: A Look into Ethereum’s Staking Yields and Its Impact on Investors

Unlocking the Potential: A Look into Ethereum’s Staking Yields and Its Impact on Investors The Current Challenge Facing Ethereum Ethereum, the second-largest cryptocurrency by market capitalization, has been a household name in the world of decentralized finance (DeFi) and blockchain technology. However, the platform is currently facing a challenge that could potentially impact its attractiveness…

Read More

NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for…

Read More